Global Decentralized Clinical Trials (DCTs) Market Growth (Status and Outlook) 2023-2029

Global Decentralized Clinical Trials (DCTs) Market Growth (Status and Outlook) 2023-2029

The FDA defines decentralized clinical trials as those executed through telemedicine and mobile or local healthcare providers, using processes and technologies that differ from the traditional clinical trial model.
Decentralized clinical trials are conducted remotely, with patient subjects remaining at home during a significant portion, or all, of the study. However, the decentralized clinical trial model is designed for more just patient participants.
LPI (LP Information)' newest research report, the “Decentralized Clinical Trials (DCTs) Industry Forecast” looks at past sales and reviews total world Decentralized Clinical Trials (DCTs) sales in 2022, providing a comprehensive analysis by region and market sector of projected Decentralized Clinical Trials (DCTs) sales for 2023 through 2029. With Decentralized Clinical Trials (DCTs) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Decentralized Clinical Trials (DCTs) industry.
This Insight Report provides a comprehensive analysis of the global Decentralized Clinical Trials (DCTs) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Decentralized Clinical Trials (DCTs) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Decentralized Clinical Trials (DCTs) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Decentralized Clinical Trials (DCTs) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Decentralized Clinical Trials (DCTs).
The global Decentralized Clinical Trials (DCTs) market size is projected to grow from US$ 6979.8 million in 2022 to US$ 18970 million in 2029; it is expected to grow at a CAGR of 15.4% from 2023 to 2029.
Global Decentralized Clinical Trials (DCTs) key players include Medidata, IQVIA, Labcorp, PRA Health Sciences, Parexel, etc. Global top five manufacturers hold a share over 45%.
North America is the largest production region, with a share about 60%, followed by Europe and Asia-Pacific, both have a share over 30 percent. In terms of product, Interventional is the largest segment, with a share over 45%. And in terms of application, the largest application is Oncology, followed by Cardiovascular, etc.
This report presents a comprehensive overview, market shares, and growth opportunities of Decentralized Clinical Trials (DCTs) market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Interventional
Observational
Expanded Access
Segmentation by application
Oncology
Cardiovascular
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Medidata
IQVIA
Labcorp
PRA Health Sciences
Parexel
ICON
Oracle
CRF Health
Clinical Ink
Medable
Science 37

Please note: The report will take approximately 2 business days to prepare and deliver.